Change in agitation in Alzheimer's disease in the placebo arm of a 9-week controlled trial

BACKGROUND: Placebo responses raise significant challenges for design of clinical trials. We report changes in agitation outcomes in the placebo arm of a recent trial of citalopram for agitation in Alzheimer's disease (AD). METHODS: In the Citalopram for Agitation in Alzheimer's Disease (C...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int Psychogeriatr
Huvudupphovsmän: Rosenberg, Paul B., Drye, Lea T., Porsteinsson, Anton P., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Newell, Jeffery, Yesavage, Jerome, Lyketsos, Constantine G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669064/
https://ncbi.nlm.nih.gov/pubmed/26305876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610215001106
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk